Log In
Print
BCIQ
Print
Print this Print this
 

Duexis, ibuprofen/famotidine (HZT-501)

Also known as: Duexa

  Manage Alerts
Collapse Summary General Information
Company Horizon Pharma Inc.
DescriptionFixed-dose combination of 800 mg ibuprofen and 26.6 mg famotidine, a histamine H2 receptor (HRH2; H2R) antagonist
Molecular Target Histamine H2 receptor (HRH2) (H2R)
Mechanism of ActionHistamine H2 receptor antagonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today